Category: Cancer Insurance

The medtech lobby advocates for cybersecurity standards after recent attacks on medical device companies, prioritizing patient safety and data protection.

A CGM study shows benefits for non-insulin users with Type 2 diabetes, lowering blood sugar levels over 26 weeks.

Medtech lobby seeks broader device eligibility for Medicare coverage of breakthrough devices with FDA authorization.

People seek the unapproved weight loss drug retatrutide online despite FDA approval pending, driven by promising clinical trial results.

Two new FDA-approved oral GLP-1 weight loss pills—Wegovy and Foundayo—offer needle-free alternatives to injectable treatments in 2026, simplifying options for p

Wisconsin APRNs gain independence under the APRN Modernization Act, but Medicare billing remains unclear for these healthcare providers.

Medicare’s 2027 fee schedule may cut payments for same-day care visits, forcing providers to split billing even when combined treatment is medically justified.

Physician moral distress drives exits, with a survey of 1,200 doctors showing 27% have quit and 25% consider leaving, underscored by an Oregon case study.

CMS mandates 5,556 specialists join the new Ambulatory Specialty Model, tying Medicare Part B payments to patient management.

Doctors advise families to limit kids' smartphone time due to health risks, with 40% of children owning tablets by age 2.